circRNA basic information
circBase ID: hsa_circ_0067741
Name: -
Synonym: circ_0067741
Host Gene: -
Genomic location(hg19): chr3:152017193-152183569:+
Genomic location(hg38): chr3:152299404-152465780:+
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005061
MONDO name: lung adenocarcinoma
Disease details: lung adenocarcinoma / LUAD
Disease DO ID:
3910
Disease MeSH ID:
C538231
Disease NCIt ID:
C3512
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

tumor tissues; adjacent non-cancerous tissues

Cell lines:

A549; Calu-3; H1299; H1975; HBE; 293 T

In vivo animal model:

-

circRNA-disease information
Expression pattern:
DN
Associated gene: LATS1, YAP, TAZ
Associated microRNA: miR-183-5p
Biological function: Inhibits LUAD cell proliferation, viability, migration, invasion and angiogenesis; promotes apoptosis.
Molecular mechanism: Acts as a miRNA sponge for miR-183-5p to up-regulate LATS1 and activate the Hippo/YAP pathway.
Biological pathway or process:

Hippo/YAP (promotes); proliferation (inhibits); migration (inhibits); invasion (inhibits); angiogenesis (inhibits); apoptosis (promotes); ceRNA regulation (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; Clinical Sample Validation; Transfection; MTT; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Tube Formation Assay; Luciferase Reporter Assay; Western Blot; Bioinformatics Analysis

Clinical significance:

circ_0067741/miR-183-5p/LATS1 axis can be a potential target for early diagnosis and targeted treatment of LUAD.

Description:

circ_0067741 is down-regulated in LUAD tissues and cell lines and functions as a tumor suppressor. It sponges miR-183-5p to increase LATS1, thereby activating Hippo/YAP signaling (increasing p-YAP and reducing YAP/TAZ activity) and inhibiting malignant phenotypes.

Confidence score:

0.6542

Other information
Title:

Circular RNA circ_0067741 regulates the Hippo/YAP pathway to suppress lung adenocarcinoma progression by targeting microRNA-183-5p.

Journal: Bioengineered
Published: 2022
PubMed ID: 35435136
Study type:

combined biological and clinical study

Data availability: The data used to support the findings of this study are included within the article.
Code availability: -